Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
8446cover_opencxd.jpg

November 13, 2006 Cover

Volume 84, Issue 46

Developing siRNA therapeutics depends on synthetic delivery systems

Credit:

Full Article
Volume 84 | Issue 46

All Issues

Biological Chemistry

Delivering RNA Interference

Developing siRNA therapeutics depends on synthetic delivery systems

  • Digging Deep To Understand siRNA Delivery Systems

  • Dow Sets Sights On R&D Breakthroughs

    Chief Technology Officer Banholzer directs the firm's scientists to pursue raw material and process advances

  • The Nuclear Weapons Dilemma

    There is desperate need for strong leadership and fresh thinking to keep nuclear weapons under control

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT